期刊文献+

代谢型谷氨酸受体4亚型(mGluR4)高通量药物筛选模型的建立 被引量:3

Development of a functional cell-based HTS assay for the identification mGluR4 modulators
原文传递
导出
摘要 为发现代谢型谷氨酸受体4亚型(mGluR4)的调节剂,通过荧光检测胞内钙浓度的方法,建立一个基于细胞功能性检测的高通量筛选(HTS)系统。将人mGluR4基因转染稳定表达Gα15蛋白的人胚肾细胞(HEK-293),用Zeocin筛选获得稳定表达mGluR4的细胞株,并通过钙流检测试验证实该细胞系的生物学功能。优化了实验系统中荧光染料的孵育时间,溶剂二甲基亚砜(DMSO)耐受性,以及溶剂氢氧化钠(NaOH)耐受性,建立了可靠稳定的筛选系统。钙流检测试验数据表明,mGluR4细胞系对其激动剂的活性程度排序是:L-(+)-2-Amino-4-phosphonobutyricacid(L-AP4)>L-Serine-O-phosphate(L-SOP)>L-Glutamicacid(L-Glu);拮抗剂是:(RS)-α-Methylserine-O-phosphate(MSOP)>(RS)-α-Methyl-4-phosphonophenylglycine(MPPG)。在96和384细胞微孔培养板中,得到该筛选系统Z’因子分别是0.80和0.65。结果表明,该稳定细胞系拥有一个稳定的检测系统,适合于mGluR4激动剂/拮抗剂的筛选。 To identify metabotropic glutamate receptor 4 (mGluR4) modulators by Ca^2+ influx assay, we developed the functional cell-based high throughput-screening (HTS) assay. The human mGluR4 cDNA was transfected into HEK-293 stably expressing promiscuous G-protein (Gα15) cells. Recombinant stable mGluR4 cell line was selected under Zeocin and validated by Ca^2+ influx assay. The assay was optimized on loading time of Fluo Calcium Indicator, Dimethyl sulfoxide (DMSO) tolerance and sodium hydroxide (NaOH) tolerance using agonist (L-Glutamic acid (L-Glu)) of mGluR4. The rank order of the agonist potency for the stable human mGluR4 cell line was L-(+)-2-Amino-4-phosphonobutyric acid (L-AP4)〉L-Serine-O-phosphate (L-SOP)〉L-Glu, and of the antagonist potency was (RS)-α-Methylserine-O-phosphate (MSOP)〉(RS)-α-Methyl-4-phosphonophenylglycine (MPPG). Z' factor value of the cell line in 96- and 384-well plate format was 0.80 and 0.65. Our data indicate a successful development of functional human mGluR4 recombinant stable cell line that was suitable for high throughput screening to identify mGluR4 agonist/antagonist.
出处 《生物工程学报》 CAS CSCD 北大核心 2009年第3期457-463,共7页 Chinese Journal of Biotechnology
关键词 代谢型谷氨酸受体4亚型(mGluR4) 高通量筛选(HTS) Gα15 激动剂/拮抗剂 metabotropic glutamate receptor 4 (mGluR4), high throughput screening (HTS), Gα15, agonist/antagonist
  • 相关文献

参考文献20

  • 1Tanabe Y, Masu M, Ishii T, et al. A family of metabotropic glutamate receptors. Neuron, 1992, 8: 169-179.
  • 2Yang ZQ. Agonists and antagonists for group Ⅲ metabotropic glutamate receptor 6, 7 and 8. Curr Top Med Chem, 2005, 5: 913-918.
  • 3Kew JN, Kemp JA. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl), 2005, 179(1): 4-29.
  • 4Mathiesen JM, Svendsen N, Brauner-Osborne H, et al. Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP. Br J Pharmacol, 2003, 138: 1026-1030.
  • 5Ferraguti F, Shigemoto R. Metabotropic glutamate receptors. Cell Tissue Res, 2006, 326(2): 483-504.
  • 6Rosemond E, Wang M, Yao Y, et al. Molecular basis for the differential agonist affinities of group Ⅲ metabotropic glutamate receptors. Mol Pharmacol, 2004, 66:834-842.
  • 7Kowal D, Nawoschik S, Ochalski R, et al. Functional calcium coupling with the human metabotropic glutamate receptor subtypes 2 and 4 by stable co-expression with a calcium pathway facilitating G-protein chimera in Chinese hamster ovary cells, Biochem Pharmacol, 2003, 66(5): 785-790.
  • 8Tanabe Y, Nomura A, Masu M, et al. Signal transduction,pharmacological properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4. JNeurosci, 1993, 13(4): 1372-1378.
  • 9Brabet, I, Parmentier ML, de Colle C, et al. Comparative effect of L-CCG-I, DCG-IV and gamma-carboxy-L- glutamate on all cloned metabotropic glutamate receptor subtypes. Neuropharmacology, 1998, 37: 1043-1051.
  • 10Gomeza J, Mary S, Brabet I, et al. Coupling of mGIuR2 and mGIuR4 to Gals, Gal6 and chimeric Gaq/i proteins: characterization of new antagonists. Mol Pharmacol, 1996, 50: 923-930.

同被引文献19

  • 1O' Brien J A, Lemaire W, Chen T B, et al. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5. Mol Pharmacol, 2003, 64 (3) :731-740.
  • 2Lavreysen H, Poul E L, Gompel P V, et al. Supersensitivity of human metabotropic glutamatela receptor signaling in L929sA cell. Mol Pharmacol 2002,61 (5) : 1244-1254.
  • 3Kouhen O E, Lehto S J, Pan J B, et al. Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist. British Journal of Pharmacology. 2006,149:761-774.
  • 4Abe T, Sugihara H, Nawa H, et al. Molecular characterization of a novel metabotropie glutamate receptor mGluR5 coupled to inositol phosphate/Ca^2+ signal transduction. The Journal of Biological Chemistry, 1992,267 (19) : 13361-13368.
  • 5Watkins J C, Jane D E. The glutamate story. British Journal of Pharmacology,2006,147 Suppl 1 :S100-S108.
  • 6Gass J T, Osborne M P, Watson N L, et al. mGluR5 antagonism attenuates methamphetamine renforcement and prevents reinstatement of methamphetamine-seeking behavior in rat. Neuropsychopharmacology ,2009,34 ( 4 ) : 820-833.
  • 7Backstrom P, Hyytia P. Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking. Neuropsychopharmacology, 2006,31 ( 4 ) :778-786.
  • 8Ayala J E, Chen Y, Banko J L, et al. mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning. Neuropsychopharmacology, 2009,34 ( 9 ) : 2057- 2071.
  • 9Mutel V, Ellis G J, Adam G, etal. Characterization of [ 3H ] quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections. Journal of Neurochemistry ,2000,75 ( 6 ) :2590-2601.
  • 10Porter R H, Jaeschke G, Spooren W,et al. Fenoban:a clinically validated nonbenzodiazcpine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity. J Pharmacol,2005,315 ( 2 ) :711-721.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部